By visiting our website or using services provided by Sai Life Sciences, you are accepting the practices described in the Privacy Policy.

We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. By continuing to use this website, you agree that we may store and access cookies on your device.

By clicking “I Accept”, you confirm that you are above the age of 16, that you have read and understood the Cookies Usage and the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Sai Life in accordance with said policies.

I accept

Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2026.03.27

Sai Life Sciences hosts Biotech Pitch Day 2026 at Boston Site

Sai Life Sciences successfully hosted its Biotech Pitch Day 2026 at its Boston-area site on March 19, bringing together a dynamic group of emerging biotech innovators, scientific leaders, and industry experts.

The event was designed as a platform for early-stage biotech companies to showcase their science, strengthen visibility, and engage with potential collaborators across the drug discovery ecosystem. As part of this initiative, participating startups also gain the opportunity to work with Sai Life Sciences—leveraging its integrated drug discovery capabilities, scientific expertise, and infrastructure to help advance their programs.

Selected from a competitive pool of applicants, ten promising startups were invited to present their work to a distinguished panel of judges and engage in meaningful discussions with peers and mentors.


Finalist Cohort
The finalists included:
Zena Therapeutics Inc., Luciole Pharmaceuticals, Inc., NuCyRNA Therapeutics, Myracle Therapeutics, AudazBio, Inc., Block Biosciences, Weld Pharmaceuticals, Cryptyx Bioscience, VISTARA BIOSCIENCE, and Neuropathix, Inc.

Recognizing Standout Innovators
Following a day of engaging presentations and discussions, three companies were recognized for their exceptional scientific rigor and compelling vision:
Block Biosciences
Neuropathix, Inc.
Zena Therapeutics Inc.
Special recognition was also extended to Cryptyx Bioscience and Tag Team Therapeutics for their strong and thoughtful pitches.

Expert Evaluation and Industry Engagement
The presentations were evaluated by an esteemed panel of judges, including Daniel Resnicow, Stephanos Ioannidis, Bharat Lagu, and Arjun Goyal. Their insights and feedback contributed to a highly engaging and enriching experience for all participants.

Driving Future Partnerships
The event builds on Sai Life Sciences’ broader initiative to support biotech startups through access to scientific expertise, infrastructure, and collaborative opportunities. Participants gained deeper visibility into Sai’s integrated drug discovery platform and explored potential pathways for collaboration.
With strong participation, high-quality science, and vibrant discussions, the Biotech Pitch Day underscored the growing importance of collaborative platforms in accelerating innovation.
Sai Life Sciences looks forward to continuing these conversations and building meaningful partnerships with the biotech community.

Share article

More News

2026.03.27

Inside Sai Life Sciences’ Integrated R&D Campus: Accelerating Drug Development

In a recent feature published in R&D World, Sai Life Sciences’ Integrated R&D Campus in Hyderabad is showcased as a model for accelerating drug discovery and development through true scientific integration.In the article, Dr. B.V.N.B.S. Sarma, Senior Vice President – Discovery, highlights how co-locating multidisciplinary teams—from medicinal chemistry and biology to DMPK, developability, process development, […]
Read more

2026.03.25

Kudikunta Lake restoration completed, marking the revival of an urban water body

Kudikunta Lake in Kondapur, Hyderabad, was inaugurated on February 28th following the completion of restoration efforts undertaken by Sai Life Sciences as part of its Corporate Social Responsibility (CSR) initiative in collaboration with the Society for Advancement of Human Endeavour (SAHE). The event marked the culmination of several months of work to restore a previously […]
Read more

2026.03.10

AI-driven retrosynthesis integrated into Discovery Chemistry

Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate an AI-driven retrosynthesis platform into its Discovery Chemistry workflows. The integration enables medicinal chemists to evaluate synthetic routes more rapidly and explore a broader set of feasible pathways during early-stage drug discovery. Retrosynthesis is a […]
Read more

2026.03.10

Structural Biology capabilities launched with X-Ray Crystallography

Sai Life Sciences has introduced integrated structural biology capabilities with the establishment of X-ray protein crystallography workflows to support structure-based drug discovery programs. The platform encompasses end-to-end protein engineering capabilities, including construct design, gene synthesis, and in-house recombinant protein expression and purification. These foundational steps enable generation of high-quality protein material suitable for structural and […]
Read more

2026.03.09

New Medicinal Chemistry block set for inauguration in Hyderabad

A new Medicinal Chemistry block, Unit VIII, is set for inauguration at IKP, Genome Valley, Hyderabad, expanding discovery capacity to meet growing program demand. The four-floor facility spans approximately 100,000 sq. ft. and is designed to support large, multi-disciplinary project teams. It accommodates more than 200 fume hoods and includes a tightly integrated analytical laboratory […]
Read more